相似文献
1
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients [Response to Letter].
Diabetes Metab Syndr Obes. 2024 Jun 5;17:2201-2202. doi: 10.2147/DMSO.S478722. eCollection 2024.
2
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients [Letter].
Diabetes Metab Syndr Obes. 2024 May 22;17:2105-2106. doi: 10.2147/DMSO.S478219. eCollection 2024.
3
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients.
Diabetes Metab Syndr Obes. 2024 May 7;17:1941-1956. doi: 10.2147/DMSO.S461349. eCollection 2024.
4
Stimulation of pancreas and gastric carcinoma cell growth by interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Gastroenterology. 1991 May;100(5 Pt 1):1338-44.
5
Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.
Hepatology. 1993 Oct;18(4):775-80. doi: 10.1002/hep.1840180405.
6
7
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.
Crit Care Med. 2012 Jan;40(1):90-7. doi: 10.1097/CCM.0b013e31822d7bf0.
8
Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment.
J Diabetes Complications. 1999 Mar-Apr;13(2):115-8. doi: 10.1016/s1056-8727(98)00025-7.
9
10
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor.
J Eur Acad Dermatol Venereol. 2002 Nov;16(6):595-8. doi: 10.1046/j.1468-3083.2002.00526.x.
本文引用的文献
1
Effects of Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor on Diabetic Lower Extremity Ulcers: Case Series of Nine Patients.
Diabetes Metab Syndr Obes. 2024 May 7;17:1941-1956. doi: 10.2147/DMSO.S461349. eCollection 2024.
2
Diagnostic accuracy of laser-evoked potentials in diabetic neuropathy.
Pain. 2017 Jun;158(6):1100-1107. doi: 10.1097/j.pain.0000000000000889.
3
Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?
Diabetes Care. 2002 Nov;25(11):2010-5. doi: 10.2337/diacare.25.11.2010.
Zotero 插件